[ad_1] DOHA, Qatar, Dec. 2, 2025 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has signed a strategic Memorandum of Understanding (MoU) with the […]
Tag: WuXi Biologics
WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index
[ad_1] The only company from pharmaceutical industry selected for inclusion in the Index Also included in HSI ESG Index and Hang Seng ESG 50 Index Green CRDMO solution provider with outstanding sustainability performance HONG KONG, […]
WuXi Biologics Included in UNGC 20 Case Examples of Sustainable Development for 20 Years Collection
[ad_1] Leading Green CRDMO Driven by Innovation for a Healthier Future Offering End-to-end Green Biologics Solutions for the Entire Industry SHANGHAI, Dec. 12, 2024 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, […]
WuXi Biologics Achieves Major Milestones at Ireland Site with Multiple 16,000L PPQ Success and HPRA GMP Authorizations
[ad_1] Multiple successful 16,000L PPQ runs highlight that disposable manufacturing can achieve similar performance as traditional stainless reactors GMP Authorizations by HPRA demonstrate that new global sites have built strong world-class regulatory and quality system […]
WuXi Biologics Achieves Major Milestones at Ireland Site with Multiple 16,000L PPQ Success and HPRA GMP Authorizations
[ad_1] Multiple successful 16,000L PPQ runs highlight that disposable manufacturing can achieve similar performance as traditional stainless reactors GMP Authorizations by HPRA demonstrate that new global sites have built strong world-class regulatory and quality system […]











